Search

Search Constraints

You searched for: Author/Creator Szamosi, T

Search Results

1. DOP007 Efficacy of vedolizumab induction therapy on clinical and endoscopic activity in patients with anti-tumour necrosis factor alpha-resistant inflammatory bowel disease. (16th January 2018)

2. P352 Ustekinumab is associated with superior treatment persistence compared to vedolizumab in Crohn's disease patients who failed to anti-TNF therapy: results from a Hungarian cohort study. (21st January 2022)

3. P441 Clinical efficacy, drug sustainability and results from therapeutic drug monitoring in Crohn's disease patients treated with ustekinumab – 1-year follow-up of a prospective, nationwide, multicenter cohort from Hungary. (27th May 2021)

4. P534 IBD-related malignancies observed in 2015–2018: 4 years' results from the prospective nationwide Hungarian registry. (25th January 2019)

5. P578 Non-medical switch between adalimumab biosimilars and from the originator adalimumab to biosimilars in inflammatory bowel disease patients – a multicentre study on efficacy and drug sustainability. (21st January 2022)

6. P605 Real life efficacy of tofacitinib in different situation in ulcerative colitis: a retrospective worldwide multicentre collaborative study. (30th January 2023)

7. P694 Non-medical mandatory reversed and back and forth switch between infliximab and its biosimilar: Early clinical outcomes. (16th January 2018)